Infliximab

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

Infliximab for Immune Checkpoint Inhibitor Associated AKI

A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Anti-Inflammatory Challenge in Schizophrenia

Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma

Precise Infliximab Exposure and Pharmacodynamic Control

Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis